Design and Pharmacology of a Highly Specific Dual FMS and KIT Kinase Inhibitor

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.1219457110
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

In Silico Design and Biological Evaluation of a Dual Specificity Kinase Inhibitor Targeting Cell Cycle Progression and Angiogenesis

PLoS ONE
Multidisciplinary
2014English

The Design and Fabrication of a Highly Compact Microstrip Dual-Band Bandpass Filter

Progress In Electromagnetics Research
2011English

A Specific Inhibitor for Tyrosine Protein Kinase From Pseudomonas.

Journal of Antibiotics
Drug DiscoveryPharmacology
1986English

Rational Design and Characterization of a Rac GTPase-specific Small Molecule Inhibitor

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2004English

FLT3 (FMS-like Tyrosine Kinase 3)

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Identification of a Dual Inhibitor of Janus Kinase 2 (JAK2) and P70 Ribosomal S6 Kinase1 (S6K1) Pathways

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2015English

Rational Design Platform to Generate Dual-Acting Kinase and Bromodomain Inhibitors

Science-Business eXchange
2014English

Highly Specific Antibodies for Co-Detection of Human Choline Kinase Α1 and Α2 Isoforms

PLoS ONE
Multidisciplinary
2010English

Robust Activity of Avapritinib, Potent and Highly Selective Inhibitor of Mutated KIT, in Patient-Derived Xenograft Models of Gastrointestinal Stromal Tumors

Clinical Cancer Research
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy